Latest News about BNTX
Recent news which mentions BNTX
Pfizer/BioNTech's Second COVID-19 Vaccine Booster Provides Short-Lived Protection In Elderly, Israel Study Shows
April 06, 2022
From Benzinga
Forget Robinhood and Buy These 2 Growth Stocks Instead
April 06, 2022
From Motley Fool
BA.2 subvariant of omicron accounted for almost 94% of global cases in latest week in latest sign of how dominant it has become
April 06, 2022
From MarketWatch
1 Red Flag and 1 Green Flag for Pfizer
April 06, 2022
From Motley Fool
From Benzinga
mRNA Vaccine Maker CEOs Pocketed $100M In Pandemic Pay: FT
April 05, 2022
From Benzinga
CDC Says Heart Inflammation Risk Higher After COVID-19 Infection Than mRNA Vaccines: CNBC
April 04, 2022
From Benzinga
Mitt Romney Says Senators Reached Tentative $10B Deal In Additional COVID-19 Relief Funding: CNBC
April 01, 2022
From Benzinga
Why Novavax Stock Dipped On Thursday
March 31, 2022
From Motley Fool
Pfizer/BioNTech's COVID- Vaccine Cuts Hospitalization Risk In Kids Aged 5-11 Years: Reuters
March 31, 2022
From Benzinga
President Biden Gets Second COVID-19 Booster, Pushes Additional Funding For Future Preparedness
March 31, 2022
From Benzinga
Biden says COVID ‘no longer controls our lives,’ but experts are worried that BA.2 is pushing cases higher in 15 states
March 31, 2022
From MarketWatch
Omicron More Severe For Unvaccinated Children Than Other Strains, Hong Kong Study Finds: Bloomberg
March 31, 2022
From Benzinga
PFE Stock: What’s Going on With Pfizer This Week?
March 30, 2022
From InvestorPlace
SPCE Stock: What’s Going on With Virgin Galactic This Week?
March 30, 2022
From InvestorPlace
BioNTech News: Why Is BNTX Stock Up Today?
March 30, 2022
From InvestorPlace
From Motley Fool
Why BioNTech Shares Are Surging Today
March 30, 2022
From Benzinga
Earnings Scheduled For March 30, 2022
March 30, 2022
From Benzinga
Omicron BA.2 Variant Represents More Than 50% COVID-19 Cases, Says CDC Estimates: WSJ
March 30, 2022
From Benzinga
Novavax Stock Is a Bet on Interest From Unvaccinated People
March 30, 2022
From InvestorPlace
From Benzinga
Why Moderna and BioNTech Were Winners Today
March 29, 2022
From Motley Fool
FDA Authorizes Fourth Dose Of Moderna, Pfizer/BioNTech COVID-19 Vaccines For Older People
March 29, 2022
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.